Literature DB >> 16227643

Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits.

Stefania Juźwiak1, Jerzy Wójcicki, Krzysztof Mokrzycki, Mariola Marchlewicz, Monika Białecka, Lidia Wenda-Rózewicka, Barbara Gawrońska-Szklarz, Marek Droździk.   

Abstract

Cardiovascular disease is currently the leading cause of death in the West, and a search for factors limiting its occurrence is ongoing. Accumulated data indicate that quercetin, the major flavonol in the plant kingdom, may possess beneficial effects in atherosclerosis. The present study aimed at determination of effects of quercetin on hyperlipidemia and development of atherosclerotic lesions in two animal models, i.e. diet induced hyperlipidemia and aortic atherosclerosis, and in injured carotid artery in rabbits fed high-fat diet for 12 and 4 weeks, respectively. It was demonstrated that quercetin was effective in reducing serum triglycerides and cholesterol levels elevated by high-fat diet, after 12 weeks of the experiment. This activity was less prominent in the 4-week study in injured carotid artery rabbit model. Hypolipemic properties of the flavonoid were associated with the reduced formation of atherosclerotic plaques, both in the aorta (12-week study) as well as within injured carotid artery (4-week study) in high-fat diet-fed animals. The surface of the intima covered with atherosclerotic plaques in high-fat diet-fed rabbits was 24.6 +/- 33.1% in comparison to 0.7 +/- 1.3% (p < 0.05) in quercetin and high-fat diet supplemented animals. It is evident from the present study that quercetin possesses both hypolipemic and antiatherogenic properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227643

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  27 in total

Review 1.  Epigenetics of inflammation, maternal infection, and nutrition.

Authors:  Kate J Claycombe; Catherine A Brissette; Othman Ghribi
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

2.  Celastrus Orbiculatus Thunb. Reduces Lipid Accumulation by Promoting Reverse Cholesterol Transport in Hyperlipidemic Mice.

Authors:  Ying Zhang; Yanhong Si; Lei Zhai; Shoudong Guo; Jilong Zhao; Hui Sang; Xiaofei Pang; Xue Zhang; Anbin Chen; Shucun Qin
Journal:  Lipids       Date:  2016-03-26       Impact factor: 1.880

3.  Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking.

Authors:  Hui Wang; Hua Wang; Jin Zhang; Jiahui Luo; Caidong Peng; Xiaoyun Tong; Xudong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

4.  Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPARγ-ABCA1 pathway.

Authors:  Liqiang Sun; En Li; Feng Wang; Tao Wang; Zhiping Qin; Shaohui Niu; Chunguang Qiu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.

Authors:  G Herrero-Beaumont; M E Marcos; O Sánchez-Pernaute; R Granados; L Ortega; E Montell; J Vergés; J Egido; R Largo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

6.  Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages.

Authors:  Yu-Cheng Chang; Tzong-Shyuan Lee; An-Na Chiang
Journal:  J Lipid Res       Date:  2012-06-18       Impact factor: 5.922

7.  Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review.

Authors:  Majambu Mbikay
Journal:  Front Pharmacol       Date:  2012-03-01       Impact factor: 5.810

8.  Cafeteria Diet-Induced Metabolic and Cardiovascular Changes in Rats: The Role of Piper nigrum Leaf Extract.

Authors:  Dorothee L E Mballa; Fanta S A Yadang; Armelle D Tchamgoue; Jean R Mba; Lauve R Y Tchokouaha; Emmanuel M Biang; Alembert T Tchinda; Désiré P Djomeni Dzeufiet; Gabriel A Agbor
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

9.  Does Quercetin Improve Cardiovascular Risk factors and Inflammatory Biomarkers in Women with Type 2 Diabetes: A Double-blind Randomized Controlled Clinical Trial.

Authors:  Maryam Zahedi; Reza Ghiasvand; Awat Feizi; Gholamreza Asgari; Leila Darvish
Journal:  Int J Prev Med       Date:  2013-07

Review 10.  The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence.

Authors:  Huan Yi; Hengyang Peng; Xinyue Wu; Xinmei Xu; Tingting Kuang; Jing Zhang; Leilei Du; Gang Fan
Journal:  Oxid Med Cell Longev       Date:  2021-06-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.